Article citationsMore>>

Kimball, A.B., Loesche, C., Prens, E.P., Bechara, F.G., Weisman, J., Rozenberg, I., et al. (2022) IL-17A Is a Pertinent Therapeutic Target for Moderate-to-Severe Hidradenitis Suppurativa: Combined Results from a Pre-Clinical and Phase II Proof-of-Concept Study. Experimental Dermatology, 31, 1522-1532.
https://doi.org/10.1111/exd.14619

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top